HLA-B and HIV infectious disease: Since it is unclear whether the protective effects of HLA-B*57 in HIV and HCV infection hold also true when HIV infection is treated by highly active antiretroviral therapy (HAART), we analyzed HLA class I associated survival in Caucasian HIV- and HCV-infected patients of the Bonn cohort.